BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 37654796)

  • 21. Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus.
    Fujii M
    Biol Pharm Bull; 2020; 43(1):12-19. PubMed ID: 31902917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release.
    Archer NK; Jo JH; Lee SK; Kim D; Smith B; Ortines RV; Wang Y; Marchitto MC; Ravipati A; Cai SS; Dillen CA; Liu H; Miller RJ; Ashbaugh AG; Uppal AS; Oyoshi MK; Malhotra N; Hoff S; Garza LA; Kong HH; Segre JA; Geha RS; Miller LS
    J Allergy Clin Immunol; 2019 Apr; 143(4):1426-1443.e6. PubMed ID: 30240702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morus alba fruits attenuates atopic dermatitis symptoms and pathology in vivo and in vitro via the regulation of barrier function, immune response and pruritus.
    Kim HM; Kang YM; Jin BR; Lee H; Lee DS; Lee M; An HJ
    Phytomedicine; 2023 Jan; 109():154579. PubMed ID: 36610150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models.
    van Drongelen V; Haisma EM; Out-Luiting JJ; Nibbering PH; El Ghalbzouri A
    Clin Exp Allergy; 2014 Dec; 44(12):1515-24. PubMed ID: 25352374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus from atopic dermatitis skin accumulates in the lysosomes of keratinocytes with induction of IL-1α secretion via TLR9.
    Moriwaki M; Iwamoto K; Niitsu Y; Matsushima A; Yanase Y; Hisatsune J; Sugai M; Hide M
    Allergy; 2019 Mar; 74(3):560-571. PubMed ID: 30269350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus.
    Bjerre RD; Holm JB; Palleja A; Sølberg J; Skov L; Johansen JD
    BMC Microbiol; 2021 Sep; 21(1):256. PubMed ID: 34551705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target.
    Zeze N; Kido-Nakahara M; Tsuji G; Maehara E; Sato Y; Sakai S; Fujishima K; Hashimoto-Hachiya A; Furue M; Nakahara T
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents.
    Luger T; Amagai M; Dreno B; Dagnelie MA; Liao W; Kabashima K; Schikowski T; Proksch E; Elias PM; Simon M; Simpson E; Grinich E; Schmuth M
    J Dermatol Sci; 2021 Jun; 102(3):142-157. PubMed ID: 34116898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of the commensal skin bacterium Staphylococcus epidermidis on the epidermal barrier and inflammation: Implications for atopic dermatitis.
    Ochlich D; Rademacher F; Drerup KA; Gläser R; Harder J
    Exp Dermatol; 2023 Apr; 32(4):555-561. PubMed ID: 36484602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Inflamed and Infected Reconstructed Human Epidermis to Study Atopic Dermatitis and Skin Care Ingredients.
    Cadau S; Gault M; Berthelemy N; Hsu CY; Danoux L; Pelletier N; Goudounèche D; Pons C; Leprince C; André-Frei V; Simon M; Pain S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the skin barrier, cutaneous microbiome and host defence peptides in canine atopic dermatitis.
    Santoro D; Saridomichelakis M; Eisenschenk M; Tamamoto-Mochizuki C; Hensel P; Pucheu-Haston C;
    Vet Dermatol; 2024 Feb; 35(1):5-14. PubMed ID: 37990608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endotypes of atopic dermatitis and food allergy.
    Hui-Beckman JW; Goleva E; Berdyshev E; Leung DYM
    J Allergy Clin Immunol; 2023 Jan; 151(1):26-28. PubMed ID: 36050129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcus aureus from atopic dermatitis skin alters cytokine production triggered by monocyte-derived Langerhans cell.
    Iwamoto K; Moriwaki M; Niitsu Y; Saino M; Takahagi S; Hisatsune J; Sugai M; Hide M
    J Dermatol Sci; 2017 Dec; 88(3):271-279. PubMed ID: 28822698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal Stem Cells and Extracellular Vesicles Derived from Canine Adipose Tissue Ameliorates Inflammation, Skin Barrier Function and Pruritus by Reducing JAK/STAT Signaling in Atopic Dermatitis.
    Kim SY; Yoon TH; Na J; Yi SJ; Jin Y; Kim M; Oh TH; Chung TW
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrier repair therapy in atopic dermatitis: an overview.
    Hon KL; Leung AK; Barankin B
    Am J Clin Dermatol; 2013 Oct; 14(5):389-99. PubMed ID: 23757122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?
    Melnik BC
    Exp Dermatol; 2014 Oct; 23(10):696-700. PubMed ID: 24889007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysbiotic Lesional Microbiome With Filaggrin Missense Variants Associate With Atopic Dermatitis in India.
    Nath S; Kumari N; Bandyopadhyay D; Sinha N; Majumder PP; Mitra R; Mukherjee S
    Front Cell Infect Microbiol; 2020; 10():570423. PubMed ID: 33282748
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of FLG loss-of-function mutations in host-microbe interactions during atopic skin inflammation.
    Oláh P; Szlávicz E; Kuchner M; Nemmer J; Zeeuwen P; Lefèvre-Utile A; Fyhrquist N; Prast-Nielsen S; Skoog T; Serra A; Rodríguez E; Raap U; Meller S; Gyulai R; Hupé P; Kere J; Levi-Schaffer F; Tsoka S; Alexander H; Nestle FO; Schröder JM; Weidinger S; van den Bogaard E; Soumelis V; Greco D; Barker J; Lauerma A; Ranki A; Andersson B; Alenius H; Homey B
    J Dermatol Sci; 2022 Jun; 106(3):132-140. PubMed ID: 35537882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon
    Möckel M; De La Cruz NC; Rübsam M; Wirtz L; Tantcheva-Poor I; Malter W; Zinser M; Bieber T; Knebel-Mörsdorf D
    J Virol; 2022 Sep; 96(17):e0086422. PubMed ID: 35969080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the Pathogenesis and Therapy of Atopic Dermatitis.
    Li H; Zhang Z; Zhang H; Guo Y; Yao Z
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):324-338. PubMed ID: 34338977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.